This award recognises excellence in programmes that engage one or more key payer/stakeholder group(s) (national, regional or European) to develop and broaden debate with clinical, governmental, public and/or other stakeholders to achieve policy change that will lead to improvements in:
Work carried out during the two-year period between January 2011 and December 2012 will be eligible. Submissions entered previously must demonstrate how the programme has been further developed during the additional time period. Entries are invited from:
| Judging criteria:
|
No results were found
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...